Metronomia

Metronomia

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Metronomia is a Germany-based, service-oriented CRO founded in 2020, specializing in biostatistics and clinical data management. With a team of more than 150 experts, the company serves global pharmaceutical and biotech clients, boasting a high repeat business rate exceeding 92% and a portfolio of over 720 projects. Its business model is built on providing flexible, high-quality statistical and data management services, positioning it as a trusted partner in clinical research rather than a developer of its own therapeutics or AI platforms.

Digital HealthAI / Machine Learning

Technology Platform

Service-oriented expertise in biostatistics and clinical data management utilizing industry-standard software (e.g., SAS, R, EDC systems) and advanced statistical methodologies.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

Growing demand for specialized biometrics outsourcing from small-to-mid-sized biotechs and sponsors seeking more personalized service than large CROs provide.
Increasing trial complexity and use of advanced analytics creates need for high-level statistical expertise.

Risk Factors

Dependence on the cyclical biopharma R&D sector.
Intense competition from large full-service CROs and niche players.
Operational risk associated with retaining specialized talent and maintaining flawless, regulatory-compliant service delivery.

Competitive Landscape

Competes in the crowded CRO market, differentiated by a focused offering on biometrics and a mid-size, high-touch service model. Key competitors range from large global CROs (IQVIA, Parexel, PPD) to numerous small boutique biostatistics firms. Its >92% repeat business suggests strong competitive retention.